Coronavirus: Merck files for U.S. approval of its Covid pill
Sylvie Claire / October 11, 2021
The American laboratory Merck announced on Monday that it had filed an application for authorization with the American authorities for its pill against Covid-19, which could constitute a major advance in the fight against the pandemic.
The application is for Merck's drug molnupiravir for the treatment of adult patients with mild to moderate forms of Covid-19 who are at risk of progressing to severe forms and/or hospitalization, the company said in a statement.
Related Posts
Denmark wakes up with almost no health restrictions
Sylvie Claire / February 1, 2022
In Denmark, there are practically no more anti-Covid restrictions. The authorities ...
Read More
Coronavirus: study finds abnormality in lungs of patients with long Covid
Sylvie Claire / January 31, 2022
In a new study, Oxford University radiology professor Fergus Gleeson used a noble g...
Read More
Jill and Joe Biden introduce Willow: Here's how the cat won the First Lady's heart
Steph Deschamps / January 29, 2022
She won Jill Biden's heart by interrupting a campaign speech: the First Lady ann...
Read More